In the face of the escalating crisis of antibiotic resistance, the emergence of a new class of antibiotics offers a promising solution to the challenge presented by drug-resistant bacteria.This innovative class, spearheaded by Kinvard Bio, aims to tackle infections that have evaded treatment through existing antibiotics.